Navigation Links
ISTA Pharmaceuticals Announces Receipt of Subpoena Relating to Promotional Practices for XIBROM(TM)
Date:4/10/2008

IRVINE, Calif., April 10 /PRNewswire-FirstCall/ -- ISTA Pharmaceuticals, Inc. (Nasdaq: ISTA), today reported that it has received a subpoena from the United States Attorney's Office in Buffalo requesting the production of documents regarding promotional, educational and other activities relating to Xibrom(TM) (bromfenac sodium ophthalmic solution) 0.09%.

It is ISTA's policy to fully comply with all applicable U.S. and foreign laws, rules and regulations of governmental agencies or other authorities. In particular, the Company's code of conduct and legal compliance statutes are intended to ensure full compliance with all laws, rules and regulations governing the sale and marketing of pharmaceutical products.

ISTA plans to fully cooperate in responding to the subpoena.

About Ista Pharmaceuticals

ISTA Pharmaceuticals is an ophthalmic pharmaceutical company. ISTA's products and product candidates addressing the $4.7 billion U.S. prescription ophthalmic industry include therapies for inflammation, ocular pain, glaucoma, allergy, and dry eye. The Company currently markets three products and is developing a strong product pipeline to fuel future growth and market share. The Company's product development and commercialization strategy is to launch a new product every 12 to 18 months, thereby continuing its growth to become the leading niche ophthalmic pharmaceutical company in the U.S. For additional information regarding ISTA, please visit ISTA Pharmaceuticals' website at http://www.istavision.com.

Any statements contained in this press release that refer to future events or other non-historical matters are forward-looking statements. Without limiting the fo
'/>"/>

SOURCE ISTA Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Aida Pharmaceuticals, Inc. Announces New Antibiotic Drug Under Development
2. Bayer HealthCare Pharmaceuticals, Amerinet Extend Contrast Media Agreement
3. Idenix Pharmaceuticals to Present at the Canaccord Adams Hepatitis C Conference
4. Indevus Pharmaceuticals Licenses European Rights for VANTAS(R) to Orion Corporation
5. ISTA Pharmaceuticals Engages Cowen as Financial Advisor
6. Alseres Pharmaceuticals, Inc. Complies With NASDAQ Rule Regarding Recently Filed 10-K
7. Barr Pharmaceuticals, Inc. Executive Bios
8. Biotest Pharmaceuticals Corporation Responds to Orphan Drug Act Announcement
9. AUDIO from Medialink and Solvay Pharmaceuticals: Men with Type 2 Diabetes at Increased Risk for Low Testosterone Should Talk to Their Doctors
10. MAP Pharmaceuticals Appoints H. Ward Wolff to Board of Directors
11. Conatus Pharmaceuticals Appoints Anthony W. Fox, MD, Ph.D., as Chief Medical Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/22/2014)... of Hematology (ASH) will present the Society,s highest honor, ... in Hematology, to Kanti R. Rai, MD, of the ... for his 50-year career combining landmark clinical leukemia research, ... care. , The Wallace H. Coulter Award for ... who has been a vital contributor to the field ...
(Date:7/22/2014)... Washington DC (PRWEB) July 22, 2014 ... in USA, launched updated payment app for Forte Payment ... credit, debit and ACH payments on iPhone, iPod and ... 2013 and has been recently updated by SIMpalm. This ... support; app is currently supported on iOS 4.3 and ...
(Date:7/22/2014)... American Conference on Lung Cancer (LALCA 2014) will be ... , Lung Cancer is still the leading cause of ... on the success of the previous conferences in Chile, ... discuss the science and advances in the treatment and ... Latin America in particular. , With tobacco being the ...
(Date:7/22/2014)... The Pennsylvania judge overseeing hundreds ... in the Philadelphia Court of Common Pleas won’t ... cases alleging the medication caused plaintiffs to develop ... In an Order dated July 18, 2014, Judge ... certify the matter for an immediate appeal to ...
(Date:7/22/2014)... The market for botulinum neurotoxin (BoNT) ... owing to novel medical indications created and due to ... societies where physical appearance is extremely valued. Although the ... competitors, new companies and technologies are setting ground for ... put the price of 1st-gen products under pressure, only ...
Breaking Medicine News(10 mins):Health News:ASH honors Kanti R. Rai, M.D., with Coulter Award for Lifetime Achievement 2Health News:ASH honors Kanti R. Rai, M.D., with Coulter Award for Lifetime Achievement 3Health News:ASH honors Kanti R. Rai, M.D., with Coulter Award for Lifetime Achievement 4Health News:SIMpalm Launched Updated Forte Mobile Payment App on iPhone and iPad for Its Client 2Health News:SIMpalm Launched Updated Forte Mobile Payment App on iPhone and iPad for Its Client 3Health News:Risperdal Lawsuit News: Pennsylvania Judge Won’t Reconsider Denial of Punitive Damages for Risperdal Gynecomastia Plaintiffs, Bernstein Liebhard LLP Reports 2Health News:Risperdal Lawsuit News: Pennsylvania Judge Won’t Reconsider Denial of Punitive Damages for Risperdal Gynecomastia Plaintiffs, Bernstein Liebhard LLP Reports 3Health News:Risperdal Lawsuit News: Pennsylvania Judge Won’t Reconsider Denial of Punitive Damages for Risperdal Gynecomastia Plaintiffs, Bernstein Liebhard LLP Reports 4Health News:Botulinum Neurotoxins Marketplace Analysed in New La Merie Publishing Report Available at MarketPublishers.com 2Health News:Botulinum Neurotoxins Marketplace Analysed in New La Merie Publishing Report Available at MarketPublishers.com 3Health News:Botulinum Neurotoxins Marketplace Analysed in New La Merie Publishing Report Available at MarketPublishers.com 4
... Public Health have found the first evidence that perfluorinated ... in everyday items such as food packaging, pesticides, clothing, ... associated with infertility in women. , ... reproductive medicine journal, the study found that women who ...
... Omaha-based SimplyWell will be presented to President ... health care in the United States.Former Speaker of the House ... hosted a special event January 26 at the National Press ... of Finding What Works." Joined by a ...
... 30 Meijer initiated a voluntary,recall of two types of ... ice cream novelties sold in all of its stores in ... from,its stores and gas stations. All sell-by dates are impacted ... has recalled the following items:, -- Meijer ...
... sugary fare may be to blame, researchers say , , ... TV more than five hours a day are prone ... suggests. , The connection? Too much time spent watching ... food choices, University of Minnesota researchers say. , "Television ...
... Jan. 30 Turner Construction Company, the nation,s ... the $323 million state-of-the-art Greenfield replacement hospital for ... manager for the project that is scheduled for ... advanced technologies in order to ensure quality clinical ...
... the American Heart Association recommends that omega-6 polyunsaturated fatty ... seeds, are beneficial when part of a heart-healthy eating ... energy (calories) from omega-6 PUFAs, and will derive most ... in the diet. Precise recommended daily servings will depend ...
Cached Medicine News:Health News:Household chemicals may be linked to infertility 2Health News:Household chemicals may be linked to infertility 3Health News:Applying the Obama Test to Healthcare: SimplyWell Cited as Top 10 Best Practices by Center for Healthcare Transformation 2Health News:Meijer Announces Voluntary Recall for Some Meijer Brand Peanuts and Ice Cream Novelties Citing Possible Health Risk 2Health News:Adult Fast-Food Diets Tied to Too Much TV as Teen 2Health News:Adult Fast-Food Diets Tied to Too Much TV as Teen 3Health News:Turner Reaches Milestone on $323 Million Virtua West Jersey Replacement Hospital in Voorhees, N.J. 2Health News:Omega-6 PUFAs and risk of cardiovascular disease 2
(Date:7/22/2014)... July 22, 2014 Cumberland Pharmaceuticals Inc. (NASDAQ: ... 2014 financial results after the market closes on Tuesday, ... webcast will be held on Tuesday, August 5, 2014, ... To participate in the call, please dial ... A rebroadcast of the teleconference will be available for ...
(Date:7/22/2014)... 22, 2014 The National Space Biomedical Research ... for Space Radiation Research (CSRR) under the leadership of ... Associate Professor of Pharmaceutical Sciences within the University of ... of Radiation Health. She is located in ... team of investigators working across four U.S. institutions, to ...
(Date:7/22/2014)... Resources Group finds that the market for interventional cardiology (IC) ... stagnant at a value of around $80 million through 2022. ... volumes are growing faster in Canada ... United States and Europe . ... penetration of PCI procedures relative to coronary artery bypass graft ...
Breaking Medicine Technology:Cumberland Pharmaceuticals To Announce Second Quarter 2014 Financial Results On August 5, 2014 2Boerma Led UAMS Team to Establish NSBRI's Center for Space Radiation Research (CSRR) 2Boerma Led UAMS Team to Establish NSBRI's Center for Space Radiation Research (CSRR) 3The Canadian Interventional Cardiology Device Market Will Remain Relatively Stagnant Through 2022 at Around $80 Million 2The Canadian Interventional Cardiology Device Market Will Remain Relatively Stagnant Through 2022 at Around $80 Million 3
... Meghan Lopresto, VP, Sales Force Automation Analytics at The ... Vaccines, will be co-presenting their expertise in interactive selling ... in Philadelphia. The conference is a ... and medical affairs professionals to discuss novel approaches to ...
... -- In 2012, Fi Asia-China, Hi & Ni ... food & beverage shows in China, will take ... Shanghai New International Expo Centre (SNIEC), organized by ... ) (Logo: http://www.prnasia.com/sa/2010/04/19/20100419602891.jpg ) ...
Cached Medicine Technology:The CementBloc and Novartis Vaccines to Jointly Present Top Considerations in Interactive Selling at the 11th Annual iPharmaConnect 2Fi Asia-China, Hi & Ni China is Ready for Return on June 2012 in Shanghai 2
For support, strength and control in your interventions, the RunWay Guide Catheter's large lumen and high-performance design represents a new era in guide catheters....
For support, strength and control in your interventions, the RunWay Guide Catheter's large lumen and high-performance design represents a new era in guide catheters....
... 20-year history, the VOYAGER RX Dilatation Catheter ... outcomes. It combines a new low profile, ... shaft,more flexible markers, and short taper balloon ... tortuous anatomy with even greater confidence, opening ...
... developed over Guidants 20-year history, the VOYAGER ... for successful treatment outcomes. It combines a ... a lower profile shaft,more flexible markers, and ... cross tight and tortuous anatomy with even ...
Medicine Products: